Skip to main content
. 2018 Nov 14;52(6):386–395. doi: 10.4132/jptm.2018.10.02

Table 4.

Univariate and multivariate Cox analysis for recurrence-free survival (n = 119)

Variable Univariate
Multivariate
HR p-value HR p-value
Age (≥ 65 yr/< 65 yr) 1.803 (0.791–4.114) .161 2.163 (0.905–5.171) .083
Sex (male/female) 1.672 (0.733–3.815) .222 - -
Multiplicity (synchronous/solitary) 2.939 (1.294–6.674) .010 - .151
T category (T3, 4/T2) 2.993 (0.403–22.224) .284 - -
N category (N1, 2/N0) 4.378 (1.623–11.805) .004 3.943 (1.457–10.670) .007
Vascular invasion (present/absent) 3.658 (1.440–9.294) .006 4.114 (1.527–11.081) .005
Lymphatic invasion (present/absent) 3.096 (1.365–7.025) .007 - .225
Perineural invasion (present/absent) 2.417 (0.952–6.136) .063 - -
Tumor location (including right colon/left colon only) 1.370 (0.509–3.690) .534 - -
Chemotherapy (treated/not-treated) 0.555 (0.130–2.369) .427 - -
Surgery (extensive/simple) 1.535 (0.456–5.169) .489 - -
MSI (MSI-H/MSS, MSI-L) 0.045 (0.000–63.182) .401 - -
KRAS (mutant/wild type) 1.776 (0.768–4.105) .179 - -

HR, hazard ratio; MSI, microsatellite instability; MSI-H, MSI-high; MSS, microsatellite-stable; MSI-L, MSI-low.